Abstract
At the start of the COVID-19 pandemic, most US K-12 schools shutdown and millions of students began remote learning. By September 2020, little guidance had been provided to school districts to inform fall teaching. This indecision led to a variety of teaching postures within a given state. In this report we examine Ohio school districts in-depth, to address whether on-premises teaching impacted COVID-19 disease outcomes in that community. We observed that counties with on-premises teaching had more cumulative deaths at the end of fall semester than counties with predominantly online teaching. To provide a measure of disease progression, we developed an observational disease model and examined multiple possible confounders, such as population size, mobility, and demographics. Examination of micropolitan counties revealed that the progression of COVID-19 disease was faster during the fall semester in counties with predominantly on-premises teaching. The relationship between increased disease prevalence in counties with on-premises teaching was not related to deaths at the start of the fall semester, population size, or the mobility within that county. This research addresses the critical question whether on-premises schooling can impact the spread of epidemic and pandemic viruses and will help inform future public policy decisions on school openings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
SSL is funded by National Institute of Allergy and Infectious Diseases (CEIRS HHSN272201400007C).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study is analysis of publicly available data and did not require IRB approval.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data is publicly available at these sources: 1. Ohio K12 data Data source: https://www.mchdata.com/covid19/schoolclosings 2. County-level daily deaths and cases from COVID-19 in Ohio State Source: John Hopkins COVID Resource (https://github.com/CSSEGISandData/COVID-19) 3. County-level population mobility (SafeGraph data from COVID-CAST API created by CMI DELPHI group). Data source: https://delphi.cmu.edu/covidcast/ 4. County-level demographic information of Ohio State (Ohio profile data from CDC). Data source: https://data.cdc.gov and https://covid.cdc.gov/covid-data-tracker/#pop-factors_7daynewcases All our code and repositories are available in the data availability link below.